• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致癌性 CALR 突变体 C 端介导双重结合到血小板生成素受体触发复合物二聚化和激活。

Oncogenic CALR mutant C-terminus mediates dual binding to the thrombopoietin receptor triggering complex dimerization and activation.

机构信息

Ludwig Institute for Cancer Research Brussels, Brussels, Belgium.

Université catholique de Louvain and de Duve Institute, Brussels, Belgium.

出版信息

Nat Commun. 2023 Apr 5;14(1):1881. doi: 10.1038/s41467-023-37277-3.

DOI:10.1038/s41467-023-37277-3
PMID:37019903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10076285/
Abstract

Calreticulin (CALR) frameshift mutations represent the second cause of myeloproliferative neoplasms (MPN). In healthy cells, CALR transiently and non-specifically interacts with immature N-glycosylated proteins through its N-terminal domain. Conversely, CALR frameshift mutants turn into rogue cytokines by stably and specifically interacting with the Thrombopoietin Receptor (TpoR), inducing its constitutive activation. Here, we identify the basis of the acquired specificity of CALR mutants for TpoR and define the mechanisms by which complex formation triggers TpoR dimerization and activation. Our work reveals that CALR mutant C-terminus unmasks CALR N-terminal domain, rendering it more accessible to bind immature N-glycans on TpoR. We further find that the basic mutant C-terminus is partially α-helical and define how its α-helical segment concomitantly binds acidic patches of TpoR extracellular domain and induces dimerization of both CALR mutant and TpoR. Finally, we propose a model of the tetrameric TpoR-CALR mutant complex and identify potentially targetable sites.

摘要

钙网织蛋白(CALR)移码突变是骨髓增殖性肿瘤(MPN)的第二个致病原因。在健康细胞中,CALR 通过其 N 端结构域短暂且非特异性地与未成熟的 N 糖基化蛋白相互作用。相反,CALR 移码突变体通过与血小板生成素受体(TpoR)稳定且特异性地相互作用,变成流氓细胞因子,从而诱导其组成性激活。在这里,我们确定了 CALR 突变体获得的与 TpoR 特异性结合的基础,并定义了复合物形成触发 TpoR 二聚化和激活的机制。我们的工作揭示了 CALR 突变体 C 端使 CALR N 端结构域暴露,使其更容易与 TpoR 上未成熟的 N 聚糖结合。我们进一步发现,碱性突变体 C 端部分呈α-螺旋结构,并定义了其α-螺旋片段如何同时结合 TpoR 细胞外结构域的酸性斑块,并诱导 CALR 突变体和 TpoR 的二聚化。最后,我们提出了一个四聚体 TpoR-CALR 突变体复合物的模型,并确定了潜在的靶标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/869c/10076285/d2c1f4ef25cb/41467_2023_37277_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/869c/10076285/7ec7d48c5c58/41467_2023_37277_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/869c/10076285/31ef39e5a256/41467_2023_37277_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/869c/10076285/30a81a07932c/41467_2023_37277_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/869c/10076285/1a405ad00dbe/41467_2023_37277_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/869c/10076285/1dba5a3b0639/41467_2023_37277_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/869c/10076285/d2c1f4ef25cb/41467_2023_37277_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/869c/10076285/7ec7d48c5c58/41467_2023_37277_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/869c/10076285/31ef39e5a256/41467_2023_37277_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/869c/10076285/30a81a07932c/41467_2023_37277_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/869c/10076285/1a405ad00dbe/41467_2023_37277_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/869c/10076285/1dba5a3b0639/41467_2023_37277_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/869c/10076285/d2c1f4ef25cb/41467_2023_37277_Fig6_HTML.jpg

相似文献

1
Oncogenic CALR mutant C-terminus mediates dual binding to the thrombopoietin receptor triggering complex dimerization and activation.致癌性 CALR 突变体 C 端介导双重结合到血小板生成素受体触发复合物二聚化和激活。
Nat Commun. 2023 Apr 5;14(1):1881. doi: 10.1038/s41467-023-37277-3.
2
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants.骨髓增殖性肿瘤相关钙网蛋白突变体对血小板生成素受体的激活作用。
Blood. 2016 Mar 10;127(10):1325-35. doi: 10.1182/blood-2015-11-681932. Epub 2015 Dec 14.
3
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms.分泌型突变钙网织蛋白作为骨髓增殖性肿瘤中的流氓细胞因子。
Blood. 2023 Feb 23;141(8):917-929. doi: 10.1182/blood.2022016846.
4
Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants.钙网织蛋白突变体作为致瘤性流氓伴侣蛋白,可与 TpoR 结合,并使 TpoR 发生转运缺陷的致病性突变。
Blood. 2019 Jun 20;133(25):2669-2681. doi: 10.1182/blood-2018-09-874578. Epub 2019 Mar 22.
5
Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation.突变型钙网蛋白的致癌转化需要其突变的C末端和血小板生成素受体。
Cancer Discov. 2016 Apr;6(4):368-81. doi: 10.1158/2159-8290.CD-15-1434. Epub 2016 Mar 7.
6
Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms.CALR 突变型骨髓增殖性肿瘤中钙网织蛋白突变激活血小板生成素受体。
Blood. 2016 Mar 10;127(10):1307-16. doi: 10.1182/blood-2015-09-671172. Epub 2016 Jan 27.
7
Novel molecular mechanism of cellular transformation by a mutant molecular chaperone in myeloproliferative neoplasms.骨髓增殖性肿瘤中突变分子伴侣介导细胞转化的新分子机制
Cancer Sci. 2017 Oct;108(10):1907-1912. doi: 10.1111/cas.13327. Epub 2017 Aug 8.
8
Mechanism underlying the development of myeloproliferative neoplasms through mutant calreticulin.通过突变钙网蛋白导致骨髓增殖性肿瘤发生的机制。
Cancer Sci. 2020 Aug;111(8):2682-2688. doi: 10.1111/cas.14503. Epub 2020 Jun 27.
9
Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody.靶向人类 CALR 突变性 MPN 祖细胞的新型表位导向单克隆抗体。
EMBO Rep. 2022 Apr 5;23(4):e52904. doi: 10.15252/embr.202152904. Epub 2022 Feb 14.
10
Homomultimerization of mutant calreticulin is a prerequisite for MPL binding and activation.突变钙网蛋白的同源多聚化是 MPL 结合和激活的前提条件。
Leukemia. 2019 Jan;33(1):122-131. doi: 10.1038/s41375-018-0181-2. Epub 2018 Jun 26.

引用本文的文献

1
Lessons from Deep Learning Structural Prediction of Multistate Multidomain Proteins-The Case Study of Coiled-Coil NOD-like Receptors.深度学习对多状态多结构域蛋白质进行结构预测的经验教训——以卷曲螺旋NOD样受体为例
Int J Mol Sci. 2025 Jan 9;26(2):500. doi: 10.3390/ijms26020500.
2
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications.骨髓增殖性肿瘤中的突变型钙网蛋白:机制见解与治疗意义
Curr Hematol Malig Rep. 2025 Jan 8;20(1):4. doi: 10.1007/s11899-024-00749-4.
3
Molecular Profile of BCR-ABL1 Negative Myeloproliferative Neoplasm in a Moroccan Population.

本文引用的文献

1
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
2
Functional Consequences of Mutations in Myeloproliferative Neoplasms.骨髓增殖性肿瘤中突变的功能后果
Hemasphere. 2021 Jun 1;5(6):e578. doi: 10.1097/HS9.0000000000000578. eCollection 2021 Jun.
3
Mechanism of mutant calreticulin-mediated activation of the thrombopoietin receptor in cancers.突变钙网织蛋白介导的癌症中血小板生成素受体激活的机制。
摩洛哥人群中 BCR-ABL1 阴性骨髓增殖性肿瘤的分子特征。
Asian Pac J Cancer Prev. 2024 Nov 1;25(11):4013-4025. doi: 10.31557/APJCP.2024.25.11.4013.
4
Lysosomal degradation targets mutant calreticulin and the thrombopoietin receptor in myeloproliferative neoplasms.溶酶体降解靶向突变钙网织蛋白和骨髓增殖性肿瘤中的血小板生成素受体。
Blood Adv. 2024 Jul 9;8(13):3372-3387. doi: 10.1182/bloodadvances.2023011432.
5
Leukemic conversion involving mutations of type 1 -mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case report.1例丙型肝炎肝硬化患者发生涉及1型突变原发性骨髓纤维化突变的白血病转化:病例报告
Front Oncol. 2023 Sep 29;13:1266996. doi: 10.3389/fonc.2023.1266996. eCollection 2023.
6
Structural Modeling of Cytokine-Receptor-JAK2 Signaling Complexes Using AlphaFold Multimer.使用 AlphaFold Multimer 对细胞因子-受体-JAK2 信号复合物进行结构建模。
J Chem Inf Model. 2023 Sep 25;63(18):5874-5895. doi: 10.1021/acs.jcim.3c00926. Epub 2023 Sep 11.
7
Structural modeling of cytokine-receptor-JAK2 signaling complexes using AlphaFold Multimer.使用AlphaFold Multimer对细胞因子受体-JAK2信号复合物进行结构建模。
bioRxiv. 2023 Jun 14:2023.06.14.544971. doi: 10.1101/2023.06.14.544971.
J Cell Biol. 2021 Jul 5;220(7). doi: 10.1083/jcb.202009179.
4
Zinc-dependent multimerization of mutant calreticulin is required for MPL binding and MPN pathogenesis.锌依赖的突变钙网蛋白多聚化对于 MPL 结合和 MPN 发病机制是必需的。
Blood Adv. 2021 Apr 13;5(7):1922-1932. doi: 10.1182/bloodadvances.2020002402.
5
Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitors.调节 MPL 信号转导以影响造血干细胞分化并抑制特发性血小板增多症祖细胞。
Proc Natl Acad Sci U S A. 2021 Jan 12;118(2). doi: 10.1073/pnas.2017849118.
6
Hematoxylin binds to mutant calreticulin and disrupts its abnormal interaction with thrombopoietin receptor.苏木精与突变钙网蛋白结合,并破坏其与血小板生成素受体的异常相互作用。
Blood. 2021 Apr 8;137(14):1920-1931. doi: 10.1182/blood.2020006264.
7
Scalable molecular dynamics on CPU and GPU architectures with NAMD.使用 NAMD 在 CPU 和 GPU 架构上进行可扩展的分子动力学。
J Chem Phys. 2020 Jul 28;153(4):044130. doi: 10.1063/5.0014475.
8
Deuteros 2.0: peptide-level significance testing of data from hydrogen deuterium exchange mass spectrometry.Deuteros 2.0:来自氢氘交换质谱的数据的肽水平显著性检验。
Bioinformatics. 2021 Apr 19;37(2):270-272. doi: 10.1093/bioinformatics/btaa677.
9
Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations.同源二聚体细胞因子受体的激活机制及致癌突变的失调。
Science. 2020 Feb 7;367(6478):643-652. doi: 10.1126/science.aaw3242.
10
DEPICTER: Intrinsic Disorder and Disorder Function Prediction Server.DEPICTER:固有无序和无序功能预测服务器。
J Mol Biol. 2020 May 15;432(11):3379-3387. doi: 10.1016/j.jmb.2019.12.030. Epub 2019 Dec 21.